?-hCG
使用说明
错误！使用“开始”选项卡将 Heading 1 应用于要在此处
显示的文字。
参考文献
1. 2. 3. 4. 5. 6. 7. 8.
Saxena B & Landesman R. Am J Obstet Gynecol 131: 97-107 (1978). Hertz JB et al. Acta Obstet Gynecol Scand 59: 23-37 (1980). Braunstein GD et al. Am J Obstet Gynecol 13: 25-32 (1978). Check JH et al. Human Reproduction 7: 1176-1180 (1992). Bagshawe KD. Adv Exp Med Biol 176: 313-324 (1984). Rosen SW et al. Ann Intern Med 82: 71-83 (1975).
Mann K et al. Scand J of Clin Lab Invest 53: suppl 216 97-104 (1993).
Summers M et al.Luminogenic Reagent Using 3-Chloro 4-HydroxyAcetanilide to Enhance Peroxidase/Luminol Chemiluminescence. Clin Chem 41. S73 (1995).
9. NCCLS. Protection of laboratory Workers from Instrument biohazards and Infectious Diseases Transmitted by Blood, Body Fluids and
tissue; Approved guideline-Second Edition. NCCLS Document M29-A2 (ISBN 1-56238-453-8). NCCLS, Wayne, PA 19087-1898; 2001. 10. Calam RR. J Clin Immunoassay 11: 86-90 (1988).
11. Rotmensch S, Cole LA. False Diagnosis and Needless Therapy of Presumed Malignant Disease in Women with False-positive Human
Chorionic Gonadotropin Concentrations. The Lancet 355: 712-715; 2000.
12. Hussa RO, Rinke ML Schweitzer PG, Discordant Human Chorionic Gonadotropin Results: Causes and Solutions. Obstet Gynecol. 65:
211-219; 1985.
13. Berglund L, Holmberg NG. Heterophilic Antibodies Against Rabbit Serum Causing Falsely Elevated Gonadotropin Levels. Acta Obstet
Gynecol Scand. 68: 377-378; 1989.
14. King IR, Doody MC. False-positive hCG by Enzyme Immunoassay Resulting in Repeated Chemotherapy. Obstet Gynecol. 86: 682-683;
1995.
15. Cole LA, Shahabi S, Butler SA, Mitchell H, Newlands ES, Behrman HR, Verrill HL. Utility of Commonly Used Commercial Human
Chorionic Gonadotropin Immunoassays in the Diagnosis and Management of Trophoblastic Diseases. Clin. Chem. 47: 308-315; 2001. 16. Levinson SS.The Nature of Heterophilic Antibodies and Their Role in Immunoassay Interference. J Clin immunoassay 15: 108-115 (1992). 17. Vladutiu AO, Sulweski JM, Pudlak KA, Stull CG. Heterophilic Antibodies Interfering with Radioimmunoassay. JAMA 248: 2489-2490; 1982. 18. Clark PM, Raggatt PR, Price CP. Antibodies Interfering in Immunometric Assays. Clin Chem. 31: 1762;1985. 19. Boscato LM, Stuart MC. Heterophilic Antibodies: A Problem for all Immunoassays. Clin Chem. 34: 27-33; 1988.
20. Weber TH, Kapyaho KI, Tanner P. Endogeneous Interference in Immunoassays in Clinical Chemistry. Scan J Clin Lab. Invest. 201: 77-82;
1990.
21. Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan Jr AC. Human Anti-Murine Immunoglobulin Responses in Patients Receiving
Monoclonal Antibody Therapy. Cancer Res 45: 879-885; 1985.
22. Tjandra JJ, Ramadi L, McKenzie IF. Development of Human Anti-Murine (HAMA) Response in Patients. Immunol Cell Biol 68: 367-376;
1998.
23. Ward G, McKinnon L, Badrick T. Hickman PE. Heterophilic Antibodies Remain a Problem for the Immunoassay Laboratory. Am J Clin Pat
hol. 108: 417-421; 1997.
24. National Committee for Clinical Laboratory Standards.Order Code EP5-T2.(1992). Evaluation of Precision Performance of Clinical
Chemistry Devices - Second Edition.
符号术语表
6 出版物编号 GEM1075_ZH 版本 1.0
使用说明
错误！使用“开始”选项卡将 Heading 1 应用于要在此处显示的文字。
?-hCG
修订记录
版本 1.0 修订日期 版本 技术变更说明* 2005-09-27 1.0 新版本技术上等同于 PIGEM1075/102.0，内容稍作如下变更： ? 用符号术语表替代符号 ? 增加修订记录栏和签名栏 * 更改栏表示相对于以前版本此文件作了哪些技术性修改。
更换此使用说明时，请在下方签署姓名和日期，并根据当地相应法规或实验室规程存档。 _________________________________ _____________ 签名 废止日期 出版物编号 GEM1075_ZH 7
?-hCG
使用说明
错误！使用“开始”选项卡将 Heading 1 应用于要在此处
显示的文字。
供货条款：按照 Ortho-Clinical Diagnostics 或其分销商的标准条款供应所有产品。如客户索取，可提供这些条款的副本。
售后服务： 地址： 邮政编码： 电话： 传真： 注册文号： 标准号：
强生（上海）医疗器材有限公司 中国上海市新华路 660 号 万宝商务中心 200052
(8621) 62826988 (8621) 62825037
国食药监械(进)字2005第3402826号 YZB/USA 1710-2005
强生公司
Ortho-Clinical Diagnostics 英国白金汉郡 海威考姆勃市
霍尔摩斯农场路 50-100 号 邮政编码：HP12 4DP
VITROS 是 Ortho-Clinical Diagnostics, Inc. 的商标。 ? Ortho-Clinical Diagnostics, Inc., 2005.
8
出版物编号 GEM1075_ZH 版本 1.0